TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs12545109
log Bayes Factor = 0.282577
Chromosome 8   position 57,313,906  (GRCh37) Explore rs12545109 on Ensembl!
Variant rs12545109 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.477 0.523
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.483 0.517
T39.0 Salicylates
0.000 0.493 0.507
T39.1 4-Aminophenol derivatives
0.000 0.509 0.491
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.563 0.437
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.580 0.420
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.598 0.402
T39.4 Antirheumatics, not elsewhere classified
0.000 0.625 0.375
T39.2 Pyrazolone derivatives
0.000 0.625 0.375
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.644 0.356
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.647 0.353
T36 Poisoning by systemic antibiotics
0.000 0.658 0.342
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.663 0.337
T43.2 Other and unspecified antidepressants
0.000 0.665 0.335
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.667 0.333
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.674 0.326
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.679 0.321
T36.0 Penicillins
0.000 0.702 0.298
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.710 0.290
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.712 0.288
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.713 0.287
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.717 0.283
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.718 0.282
T40.2 Other opioids
0.000 0.723 0.277
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.724 0.276
T36.3 Macrolides
0.000 0.728 0.271
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.733 0.267
T43.9 Psychotropic drug, unspecified
0.000 0.735 0.265
T48.5 Anti-common-cold drugs
0.000 0.737 0.263
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.737 0.263
T40.3 Methadone
0.000 0.739 0.261
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.741 0.259
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.744 0.256
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.744 0.255
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.747 0.253
T46.7 Peripheral vasodilators
0.000 0.747 0.253
T40.1 Heroin
0.000 0.749 0.251
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.750 0.250
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.753 0.247
T40.5 Cocaine
0.000 0.753 0.247
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.754 0.246
T36.9 Systemic antibiotic, unspecified
0.000 0.755 0.245
T36.7 Antifungal antibiotics, systemically used
0.000 0.755 0.245
T36.6 Rifamycins
0.000 0.755 0.245
T36.5 Aminoglycosides
0.000 0.755 0.245
T36.2 Chloramphenicol group
0.000 0.755 0.245
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.755 0.244
T50.1 Loop [high-ceiling] diuretics
0.000 0.757 0.243
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.759 0.241
T40.6 Other and unspecified narcotics
0.000 0.759 0.241
T36.4 Tetracyclines
0.000 0.761 0.239
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.761 0.239
T40.8 Lysergide [LSD]
0.000 0.761 0.239
T40.7 Cannabis (derivatives)
0.000 0.761 0.239
T40.0 Opium
0.000 0.761 0.239
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.762 0.237
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.764 0.236
T43.6 Psychostimulants with abuse potential
0.000 0.764 0.236
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.765 0.235
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.766 0.234
T48.4 Expectorants
0.000 0.766 0.234
T48.3 Antitussives
0.000 0.766 0.234
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.766 0.234
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.766 0.234
T48.0 Oxytocic drugs
0.000 0.766 0.234
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.769 0.231
T50.7 Analeptics and opioid receptor antagonists
0.000 0.770 0.230
T50.5 Appetite depressants
0.000 0.770 0.230
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.770 0.230
T50.0 Mineralocorticoids and their antagonists
0.000 0.770 0.230
T50.4 Drugs affecting uric acid metabolism
0.000 0.772 0.228
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.775 0.225
T36.8 Other systemic antibiotics
0.000 0.781 0.219
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.782 0.217
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.790 0.210
T50.8 Diagnostic agents
0.000 0.791 0.209
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.791 0.209
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.792 0.208
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.792 0.208
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.792 0.208
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.792 0.208
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.792 0.208
T44.0 Anticholinesterase agents
0.000 0.792 0.208
T41.5 Therapeutic gases
0.000 0.793 0.207
T41.4 Anaesthetic, unspecified
0.000 0.793 0.207
T41.3 Local anaesthetics
0.000 0.793 0.207
T41.1 Intravenous anaesthetics
0.000 0.793 0.207
T41.0 Inhaled anaesthetics
0.000 0.793 0.207
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.793 0.206
T49.9 Topical agent, unspecified
0.000 0.794 0.206
T49.8 Other topical agents
0.000 0.794 0.206
T49.7 Dental drugs, topically applied
0.000 0.794 0.206
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.794 0.206
T49.5 Ophthalmological drugs and preparations
0.000 0.794 0.206
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.794 0.206
T49.3 Emollients, demulcents and protectants
0.000 0.794 0.206
T49.2 Local astringents and local detergents
0.000 0.794 0.206
T49.1 Antipruritics
0.000 0.794 0.206
T41.2 Other and unspecified general anaesthetics
0.000 0.794 0.206
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.795 0.205
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.795 0.204
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.798 0.202
T46.1 Calcium-channel blockers
0.000 0.801 0.199
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.805 0.194
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.808 0.191
T37.5 Antiviral drugs
0.000 0.808 0.191
T37.4 Anthelminthics
0.000 0.808 0.191
T37.3 Other antiprotozoal drugs
0.000 0.808 0.191
T37.1 Antimycobacterial drugs
0.000 0.808 0.191
T37.0 Sulphonamides
0.000 0.808 0.191
T40.4 Other synthetic narcotics
0.000 0.810 0.190
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.811 0.189
T38.9 Other and unspecified hormone antagonists
0.000 0.814 0.186
T38.7 Androgens and anabolic congeners
0.000 0.814 0.186
T38.5 Other oestrogens and progestogens
0.000 0.814 0.186
T38.4 Oral contraceptives
0.000 0.814 0.186
T38.2 Antithyroid drugs
0.000 0.814 0.186
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.815 0.185
T38.1 Thyroid hormones and substitutes
0.000 0.816 0.184
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.823 0.177
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.828 0.171
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.830 0.170
T38.0 Glucocorticoids and synthetic analogues
0.000 0.834 0.166
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.834 0.165
T47.2 Stimulant laxatives
0.000 0.838 0.162
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.844 0.156
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.844 0.156
T47.7 Emetics
0.000 0.844 0.156
T47.5 Digestants
0.000 0.844 0.156
T47.3 Saline and osmotic laxatives
0.000 0.844 0.156
T45.5 Anticoagulants
0.000 0.847 0.152
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.848 0.152
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.849 0.151
T45.8 Other primarily systemic and haematological agents
0.000 0.849 0.151
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.849 0.151
T45.6 Fibrinolysis-affecting drugs
0.000 0.849 0.151
T45.4 Iron and its compounds
0.000 0.849 0.151
T45.3 Enzymes, not elsewhere classified
0.000 0.849 0.151
T47.6 Antidiarrhoeal drugs
0.000 0.851 0.149
T47.4 Other laxatives
0.000 0.851 0.149
T42.3 Barbiturates
0.000 0.855 0.145
T45.2 Vitamins, not elsewhere classified
0.000 0.857 0.142
T47.0 Histamine H(2)-receptor antagonists
0.000 0.861 0.139
T45.0 Antiallergic and antiemetic drugs
0.000 0.864 0.135
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.867 0.133
T42.2 Succinimides and oxazolidinediones
0.000 0.867 0.133
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.869 0.131
T42.1 Iminostilbenes
0.000 0.873 0.127
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.874 0.126
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.890 0.110
T42.0 Hydantoin derivatives
0.000 0.894 0.105
T42.4 Benzodiazepines
0.000 0.909 0.090
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.916 0.084
C85.1 B-cell lymphoma, unspecified
0.070 0.930 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.070 0.930 0.000
C92 Myeloid leukaemia
0.067 0.933 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.065 0.935 0.000
C92.1 Chronic myeloid leukaemia
0.065 0.935 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.064 0.936 0.000
C92.0 Acute myeloid leukaemia
0.062 0.938 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.061 0.939 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.054 0.946 0.000
C92.9 Myeloid leukaemia, unspecified
0.054 0.946 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.053 0.947 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.051 0.949 0.000
C85.0 Lymphosarcoma
0.050 0.950 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.050 0.950 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.050 0.950 0.000
C92.4 Acute promyelocytic leukaemia
0.050 0.950 0.000
C92.5 Acute myelomonocytic leukaemia
0.048 0.952 0.000
C94 Other leukaemias of specified cell type
0.048 0.952 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.048 0.952 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.048 0.952 0.000
C92.3 Myeloid sarcoma
0.048 0.952 0.000
C92.2 Subacute myeloid leukaemia
0.048 0.952 0.000
C82.3 Follicular lymphoma grade IIIa
0.048 0.952 0.000
C93 Monocytic leukaemia
0.048 0.952 0.000
C91 Lymphoid leukaemia
0.047 0.953 0.000
C86 Other specified types of T/NK-cell lymphoma
0.047 0.953 0.000
C92.7 Other myeloid leukaemia
0.047 0.953 0.000
C82.2 Large cell, follicular
0.047 0.953 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.046 0.954 0.000
C95 Leukaemia of unspecified cell type
0.044 0.956 0.000
C82.6 Cutaneous follicle centre lymphoma
0.044 0.956 0.000
C82.5 Diffuse follicle centre lymphoma
0.044 0.956 0.000
C88 Malignant immunoproliferative diseases
0.041 0.959 0.000
C81 Hodgkin's disease
0.041 0.959 0.000
C82.0 Small cleaved cell, follicular
0.040 0.960 0.000
C82.4 Follicular lymphoma grade IIIb
0.040 0.960 0.000
C91.1 Chronic lymphocytic leukaemia
0.040 0.960 0.000
C93.1 Chronic monocytic leukaemia
0.036 0.964 0.000
C94.4 Acute panmyelosis
0.036 0.964 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.036 0.964 0.000
C95.9 Leukaemia, unspecified
0.035 0.965 0.000
C91.5 Adult T-cell leukaemia
0.035 0.965 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.035 0.965 0.000
C94.7 Other specified leukaemias
0.035 0.965 0.000
C94.5 Acute myelofibrosis
0.035 0.965 0.000
C94.3 Mast cell leukaemia
0.035 0.965 0.000
C94.2 Acute megakaryoblastic leukaemia
0.035 0.965 0.000
C94.1 Chronic erythraemia
0.035 0.965 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.035 0.965 0.000
C93.9 Monocytic leukaemia, unspecified
0.034 0.965 0.000
C93.7 Other monocytic leukaemia
0.034 0.965 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.034 0.965 0.000
C93.2 Subacute monocytic leukaemia
0.034 0.965 0.000
C93.0 Acute monocytic leukaemia
0.034 0.965 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.034 0.966 0.000
C91.7 Other lymphoid leukaemia
0.034 0.966 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.034 0.966 0.000
C91.3 Prolymphocytic leukaemia
0.034 0.966 0.000
C91.2 Subacute lymphocytic leukaemia
0.034 0.966 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.034 0.966 0.000
C91.9 Lymphoid leukaemia, unspecified
0.034 0.966 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.034 0.966 0.000
C86.4 Blastic NK-cell lymphoma
0.034 0.966 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.034 0.966 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.034 0.966 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.034 0.966 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.034 0.966 0.000
C81.1 Nodular sclerosis
0.033 0.967 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.033 0.967 0.000
C96.8 Histiocytic sarcoma
0.033 0.967 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.033 0.967 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.033 0.967 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.033 0.967 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.033 0.967 0.000
C96.3 True histiocytic lymphoma
0.033 0.967 0.000
C96.2 Malignant mast cell tumour
0.033 0.967 0.000
C96.1 Malignant histiocytosis
0.033 0.967 0.000
C96.0 Letterer-Siwe disease
0.033 0.967 0.000
C95.7 Other leukaemia of unspecified cell type
0.032 0.968 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.032 0.968 0.000
C91.4 Hairy-cell leukaemia
0.031 0.968 0.000
C81.2 Mixed cellularity
0.031 0.968 0.000
C81.7 Other Hodgkin's disease
0.031 0.969 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.030 0.970 0.000
C88.7 Other malignant immunoproliferative diseases
0.030 0.970 0.000
C88.3 Immunoproliferative small intestinal disease
0.030 0.970 0.000
C88.2 Gamma heavy chain disease
0.030 0.970 0.000
C88.1 Alpha heavy chain disease
0.030 0.970 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.029 0.970 0.000
C81.3 Lymphocytic depletion
0.029 0.970 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.029 0.970 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.029 0.971 0.000
C83.1 Small cleaved cell (diffuse)
0.029 0.971 0.000
C95.0 Acute leukaemia of unspecified cell type
0.028 0.971 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.028 0.972 0.000
C91.0 Acute lymphoblastic leukaemia
0.028 0.972 0.000
C81.0 Lymphocytic predominance
0.028 0.972 0.000
C83.0 Small cell (diffuse)
0.026 0.973 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.026 0.974 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.025 0.975 0.000
C83.5 Lymphoblastic (diffuse)
0.025 0.975 0.000
C83.6 Undifferentiated (diffuse)
0.025 0.975 0.000
C83.4 Immunoblastic (diffuse)
0.025 0.975 0.000
C83.2 Mixed small and large cell (diffuse)
0.025 0.975 0.000
C83.7 Burkitt's tumour
0.023 0.977 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.023 0.977 0.000
G40.3 Generalised idiopathic epilepsy and epileptic syndromes
0.021 0.979 0.000
C90.3 Solitary plasmacytoma
0.021 0.979 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.020 0.979 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.020 0.979 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.020 0.979 0.000
C84.3 Lymphoepithelioid lymphoma
0.020 0.979 0.000
C84.2 T-zone lymphoma
0.020 0.979 0.000
C84.1 Sezary's diease
0.020 0.979 0.000
C84.0 Mycosis fungoides
0.020 0.980 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.018 0.982 0.000
G40 Epilepsy
0.018 0.982 0.000
C84.5 Other and unspecified T-cell lymphomas
0.017 0.982 0.000
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
0.017 0.983 0.000
C84.4 Peripheral T-cell lymphoma
0.016 0.983 0.000
C90.1 Plasma cell leukaemia
0.016 0.983 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.016 0.983 0.000
G40.5 Special epileptic syndromes
0.016 0.984 0.000
G40.8 Other epilepsy
0.015 0.985 0.000
N20.2 Calculus of kidney with calculus of ureter
0.000 0.985 0.015
C90.2 Plasmacytoma, extramedullary
0.014 0.986 0.000
C83.3 Large cell (diffuse)
0.014 0.986 0.000
G40.7 Petit mal, unspecified, without grand mal seizures
0.014 0.986 0.000
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset
0.014 0.986 0.000
N41.1 Chronic prostatitis
0.013 0.987 0.000
G40.9 Epilepsy, unspecified
0.013 0.987 0.000
G40.4 Other generalised epilepsy and epileptic syndromes
0.012 0.987 0.000
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
0.012 0.988 0.000
G40.6 Grand mal seizures, unspecified (with or without petit mal)
0.012 0.988 0.000
C81.9 Hodgkin's disease, unspecified
0.011 0.988 0.001
R49.0 Dysphonia
0.000 0.990 0.010
C15 Malignant neoplasm of oesophagus
0.000 0.990 0.010
C15.4 Middle third of oesophagus
0.000 0.990 0.010
C15.9 Oesophagus, unspecified
0.000 0.991 0.009
C15.3 Upper third of oesophagus
0.000 0.991 0.009
O24.4 Diabetes mellitus arising in pregnancy
0.009 0.991 0.000
C15.5 Lower third of oesophagus
0.000 0.992 0.008
Z45.8 Adjustment and management of other implanted devices
0.000 0.992 0.008
C15.1 Thoracic part of oesophagus
0.000 0.993 0.007
C15.0 Cervical part of oesophagus
0.000 0.993 0.007
C15.8 Overlapping lesion of oesophagus
0.000 0.993 0.007
C15.2 Abdominal part of oesophagus
0.000 0.993 0.007
I35.0 Aortic (valve) stenosis
0.000 0.993 0.007
D68 Other coagulation defects
0.000 0.993 0.007
C90.0 Multiple myeloma
0.007 0.993 0.000
D68.3 Haemorrhagic disorder due to circulating anticoagulants
0.000 0.993 0.007
D68.9 Coagulation defect, unspecified
0.000 0.993 0.007
D68.0 Von Willebrand's disease
0.000 0.993 0.007
N41 Inflammatory diseases of prostate
0.007 0.993 0.000
N41.0 Acute prostatitis
0.007 0.993 0.000
F31.0 Bipolar affective disorder, current episode hypomanic
0.000 0.993 0.007
D68.6 Other Thrombophilia
0.000 0.993 0.006
D68.8 Other specified coagulation defects
0.000 0.994 0.006
F33.9 Recurrent depressive disorder, unspecified
0.000 0.994 0.006
F33 Recurrent depressive disorder
0.000 0.994 0.006
F31 Bipolar affective disorder
0.000 0.994 0.006
D68.4 Acquired coagulation factor deficiency
0.000 0.994 0.006
C16.9 Stomach, unspecified
0.000 0.994 0.006
S39.9 Unspecified injury of abdomen, lower back and pelvis
0.006 0.994 0.000
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms
0.000 0.994 0.006
I35.8 Other aortic valve disorders
0.000 0.995 0.005
I35 Nonrheumatic aortic valve disorders
0.000 0.995 0.005
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms
0.000 0.995 0.005
D68.5 Primary Thrombophilia
0.000 0.995 0.005
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms
0.000 0.995 0.005
R49 Voice disturbances
0.000 0.995 0.005
N41.2 Abscess of prostate
0.005 0.995 0.000
D68.1 Hereditary factor XI deficiency
0.000 0.995 0.005
F31.6 Bipolar affective disorder, current episode mixed
0.000 0.995 0.005
I85.9 Oesophageal varices without bleeding
0.005 0.995 0.000
N41.3 Prostatocystitis
0.005 0.995 0.000
F31.8 Other bipolar affective disorders
0.000 0.995 0.005
I35.1 Aortic (valve) insufficiency
0.000 0.995 0.005
N41.8 Other inflammatory diseases of prostate
0.005 0.995 0.000
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.995 0.005
F33.0 Recurrent depressive disorder, current episode mild
0.000 0.995 0.005
Z83.3 Family history of diabetes mellitus
0.000 0.995 0.005
L72.9 Follicular cyst of skin and subcutaneous tissue, unspecified
0.005 0.995 0.000
F33.1 Recurrent depressive disorder, current episode moderate
0.000 0.995 0.005
F33.4 Recurrent depressive disorder, currently in remission
0.000 0.995 0.004
I35.9 Aortic valve disorder, unspecified
0.000 0.996 0.004
O24 Diabetes mellitus in pregnancy
0.004 0.996 0.000
D69.3 Idiopathic thrombocytopenic purpura
0.000 0.996 0.004
F31.9 Bipolar affective disorder, unspecified
0.000 0.996 0.004
F30-F39 Mood [affective] disorders
0.000 0.996 0.004
F33.8 Other recurrent depressive disorders
0.000 0.996 0.004
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms
0.000 0.996 0.004
R49.2 Hypernasality and hyponasality
0.000 0.996 0.004
R49.1 Aphonia
0.000 0.996 0.004
L85.9 Epidermal thickening, unspecified
0.004 0.996 0.000
F30 Manic episode
0.000 0.996 0.004
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms
0.000 0.996 0.004
F31.3 Bipolar affective disorder, current episode mild or moderate depression
0.000 0.996 0.004
O24.0 Pre-existing diabetes mellitus, insulin-dependent
0.004 0.996 0.000
R49.8 Other and unspecified voice disturbances
0.000 0.996 0.003
C16 Malignant neoplasm of stomach
0.000 0.996 0.004
F34 Persistent mood [affective] disorders
0.000 0.996 0.003
F31.7 Bipolar affective disorder, currently in remission
0.000 0.996 0.003
J93.1 Other spontaneous pneumothorax
0.000 0.996 0.003
O24.3 Pre-existing diabetes mellitus, unspecified
0.003 0.997 0.000
O24.2 Pre-existing malnutrition-related diabetes mellitus
0.003 0.997 0.000
O24.1 Pre-existing diabetes mellitus, noninsulin-dependent
0.003 0.997 0.000
D03.7 Melanoma in situ of lower limb, including hip
0.003 0.997 0.000
O24.9 Diabetes mellitus in pregnancy, unspecified
0.003 0.997 0.000
C16.3 Pyloric antrum
0.000 0.997 0.003
F30.2 Mania with psychotic symptoms
0.000 0.997 0.003
F34.1 Dysthymia
0.000 0.997 0.003
F30.9 Manic episode, unspecified
0.000 0.997 0.003
S39 Other and unspecified injuries of abdomen, lower back and pelvis
0.003 0.997 0.000
R47.1 Dysarthria and anarthria
0.000 0.997 0.003
I85 Oesophageal varices
0.003 0.997 0.000
D68.2 Hereditary deficiency of other clotting factors
0.000 0.997 0.003
F30.1 Mania without psychotic symptoms
0.000 0.997 0.003
I85.0 Oesophageal varices with bleeding
0.003 0.997 0.000
C16.4 Pylorus
0.000 0.997 0.003
K26.3 Acute without haemorrhage or perforation
0.003 0.997 0.000
F38 Other mood [affective] disorders
0.000 0.997 0.003
F30.8 Other manic episodes
0.000 0.997 0.003
S62.40 Multiple fractures of metacarpal bones (closed)
0.000 0.997 0.003
O61.0 Failed medical induction of labour
0.003 0.997 0.000
R47-R49 Symptoms and signs involving speech and voice
0.000 0.997 0.003
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions
0.000 0.997 0.003
K76.6 Portal hypertension
0.003 0.997 0.000
F30.0 Hypomania
0.000 0.997 0.003
F34.9 Persistent mood [affective] disorder, unspecified
0.000 0.997 0.003
F34.8 Other persistent mood [affective] disorders
0.000 0.997 0.003
G24.9 Dystonia, unspecified
0.003 0.997 0.000
S39.8 Other specified injuries of abdomen, lower back and pelvis
0.003 0.997 0.000
C16.6 Greater curvature of stomach, unspecified
0.000 0.997 0.003
C25.2 Tail of pancreas
0.000 0.997 0.003
I35.2 Aortic (valve) stenosis with insufficiency
0.000 0.997 0.003
C16.8 Overlapping lesion of stomach
0.000 0.997 0.003
S39.0 Injury of muscle and tendon of abdomen, lower back and pelvis
0.003 0.997 0.000
C23 Malignant neoplasm of gallbladder
0.000 0.997 0.003
C17 Malignant neoplasm of small intestine
0.000 0.997 0.003
C17.2 Ileum
0.000 0.997 0.003
C16.2 Body of stomach
0.000 0.997 0.002
R47 Speech disturbances, not elsewhere classified
0.000 0.997 0.003
D69 Purpura and other haemorrhagic conditions
0.000 0.997 0.003
F34.0 Cyclothymia
0.000 0.997 0.002
S39.7 Other multiple injuries of abdomen, lower back and pelvis
0.002 0.997 0.000
S39.6 Injury of intra-abdominal organ(s) with pelvic organ(s)
0.002 0.997 0.000
Z22.3 Carrier of other specified bacterial diseases
0.003 0.997 0.000
C16.1 Fundus of stomach
0.000 0.997 0.002
E22.0 Acromegaly and pituitary gigantism
0.000 0.997 0.003
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms
0.000 0.997 0.002
G24 Dystonia
0.002 0.997 0.000
G25.3 Myoclonus
0.002 0.997 0.000
G41.9 Status epilepticus, unspecified
0.002 0.998 0.000
F39 Unspecified mood [affective] disorder
0.000 0.998 0.002
R52.9 Pain, unspecified
0.002 0.998 0.000
F38.1 Other recurrent mood [affective] disorders
0.000 0.998 0.002
C15-C26 Malignant neoplasms of digestive organs
0.000 0.998 0.002
R48 Dyslexia and other symbolic dysfunctions, not elsewhere classified
0.000 0.998 0.002
C16.5 Lesser curvature of stomach, unspecified
0.000 0.998 0.002
C17.0 Duodenum
0.000 0.998 0.002
N41.9 Inflammatory disease of prostate, unspecified
0.002 0.998 0.000
D65 Disseminated intravascular coagulation [defibrination syndrome]
0.000 0.998 0.002
R90.0 Intracranial space-occupying lesion
0.002 0.998 0.000
C16.0 Cardia
0.000 0.998 0.002
F38.0 Other single mood [affective] disorders
0.000 0.998 0.002
D69.0 Allergic purpura
0.000 0.998 0.002
Y83.6 Removal of other organ (partial) (total)
0.002 0.998 0.000
F38.8 Other specified mood [affective] disorders
0.000 0.998 0.002
C25.4 Endocrine pancreas
0.000 0.998 0.002
J84.1 Other interstitial pulmonary diseases with fibrosis
0.002 0.998 0.000
C25 Malignant neoplasm of pancreas
0.000 0.998 0.002
G25 Other extrapyramidal and movement disorders
0.002 0.998 0.000
C17.1 Jejunum
0.000 0.998 0.002
G24.5 Blepharospasm
0.002 0.998 0.000
G24.3 Spasmodic torticollis
0.002 0.998 0.000
D69.1 Qualitative platelet defects
0.000 0.998 0.002
M19.98 Arthrosis, unspecified (Other)
0.002 0.998 0.000
C17.8 Overlapping lesion of small intestine
0.000 0.998 0.002
C17.3 Meckel's diverticulum
0.000 0.998 0.002
D69.2 Other nonthrombocytopenic purpura
0.000 0.998 0.002
C25.7 Other parts of pancreas
0.000 0.998 0.002
G24.0 Drug-induced dystonia
0.002 0.998 0.000
C17.9 Small intestine, unspecified
0.000 0.998 0.002
R47.0 Dysphasia and aphasia
0.000 0.998 0.002
D67 Hereditary factor IX deficiency
0.000 0.998 0.002
R48.0 Dyslexia and alexia
0.000 0.998 0.002
G20-G26 Extrapyramidal and movement disorders
0.002 0.998 0.000
G24.4 Idiopathic orofacial dystonia
0.002 0.998 0.000
G24.2 Idiopathic nonfamilial dystonia
0.002 0.998 0.000
F10.2 Dependence syndrome
0.000 0.998 0.002
R79.9 Abnormal finding of blood chemistry, unspecified
0.002 0.998 0.000
D69.8 Other specified haemorrhagic conditions
0.000 0.998 0.002
G20 Parkinson's disease
0.002 0.998 0.000
D69.4 Other primary thrombocytopenia
0.000 0.998 0.002
I24.8 Other forms of acute ischaemic heart disease
0.000 0.998 0.002
G25.1 Drug-induced tremor
0.002 0.998 0.000
R48.2 Apraxia
0.000 0.998 0.002
R48.1 Agnosia
0.000 0.998 0.002
G24.8 Other dystonia
0.002 0.998 0.000
D66 Hereditary factor VIII deficiency
0.000 0.998 0.002
D69.9 Haemorrhagic condition, unspecified
0.000 0.998 0.002
G25.9 Extrapyramidal and movement disorder, unspecified
0.002 0.998 0.000
O63.0 Prolonged first stage (of labour)
0.002 0.998 0.000
G25.0 Essential tremor
0.002 0.998 0.000
R48.8 Other and unspecified symbolic dysfunctions
0.000 0.998 0.002
J93 Pneumothorax
0.000 0.998 0.002
G25.2 Other specified forms of tremor
0.002 0.998 0.000
J93.0 Spontaneous tension pneumothorax
0.000 0.998 0.002
G25.6 Drug-induced tics and other tics of organic origin
0.002 0.998 0.000
G25.4 Drug-induced chorea
0.002 0.998 0.000
G24.1 Idiopathic familial dystonia
0.002 0.998 0.000
G21 Secondary Parkinsonism
0.002 0.998 0.000
G59.0 Diabetic mononeuropathy
0.002 0.998 0.000
G23 Other degenerative diseases of basal ganglia
0.002 0.998 0.000
G26 Extrapyramidal and movement disorders in diseases classified elsewhere
0.002 0.998 0.000
G22 Parkinsonism in diseases classified elsewhere
0.002 0.998 0.000
G41 Status epilepticus
0.002 0.998 0.000
M24.13 Other articular cartilage disorders (Forearm)
0.002 0.998 0.000
C25.8 Overlapping lesion of pancreas
0.000 0.998 0.002
C25.1 Body of pancreas
0.000 0.998 0.002
C71.2 Temporal lobe
0.002 0.998 0.000
S02.00 Fracture of vault of skull (closed)
0.002 0.998 0.000
D75.9 Disease of blood and blood-forming organs, unspecified
0.002 0.998 0.000
J93.8 Other pneumothorax
0.000 0.998 0.002
M47.90 Spondylosis, unspecified (Multiple sites in spine)
0.000 0.998 0.002
B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
0.000 0.998 0.002
G25.5 Other chorea
0.002 0.998 0.000
J84.9 Interstitial pulmonary disease, unspecified
0.002 0.998 0.000
C71.0 Cerebrum, except lobes and ventricles
0.002 0.998 0.000
G21.9 Secondary Parkinsonism, unspecified
0.002 0.998 0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract
0.000 0.998 0.002
D03.3 Melanoma in situ of other and unspecified parts of face
0.002 0.998 0.000
C71.3 Parietal lobe
0.002 0.998 0.000
G21.4 Vascular parkinsonism
0.001 0.998 0.000
O12.1 Gestational proteinuria
0.000 0.998 0.002
M19.96 Arthrosis, unspecified-Lower leg
0.000 0.998 0.002
I74.2 Embolism and thrombosis of arteries of the upper extremities
0.000 0.998 0.002
E85.4 Organ-limited amyloidosis
0.002 0.998 0.000
D03 Melanoma in situ
0.002 0.998 0.000
M07.30 Other psoriatic arthropathies (Multiple sites)
0.002 0.998 0.000
G21.8 Other secondary Parkinsonism
0.001 0.998 0.000
G21.3 Postencephalitic Parkinsonism
0.001 0.998 0.000
G21.2 Secondary Parkinsonism due to other external agents
0.001 0.998 0.000
G21.0 Malignant neuroleptic syndrome
0.001 0.998 0.000
G23.8 Other specified degenerative diseases of basal ganglia
0.001 0.998 0.000
Z90.3 Acquired absence of part of stomach
0.000 0.998 0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2026 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.